Kochanova visits children's cancer center to wish Happy New Year

Chairwoman of the Council of the Republic Natalya Kochanova visited the National Scientific and Practical Center for Pediatric Oncology, Hematology and Immunology and gave it a certificate for a light microscope for hematology on 24 December, BelTA has learned.

"A board of trustees has been set up at the initiative of the Council of the Republic. We are grateful to the members of the Council of the Republic who have actively joined in this work. We are giving this certificate for the light microscope so that your center could provide more qualified medical care to children," said Natalya Kochanova.

The speaker expressed support for the initiative of the center's employees to build and equip a five-story surgical center. "The center is doing a really great job. You even provide medical care to the children from other countries," she said..

Natalya Kochanova also thanked doctors for their hard work. “First of all, I would like to wish you strong health, good luck, success, and prosperity. I know, it is not just a job for you, it means life for you. Let everything go well with you and most importantly, let the children treated here be healthy,” the chairperson of the Council of the Republic said.

Natalya Kochanova paid a visit to patients in the center. The children were given sweets and stuffed toys.

According to Mikhail Belevtsev, Deputy Director for Science at the center, the light microscope for hematology plays a key role in diagnosing the disease at the first and most important stage. “This microscope is designed to analyze bone marrow cells. It is one of the microscopes that help diagnose acute leukemia. A child undergoes a bone marrow puncture or a peripheral blood smear, and if tumor cells are found there, they are evaluated under this microscope,” he said.

The Belarusian Research Center for Pediatric Oncology, Hematology and Immunology provides specialized medical care to patients from all regions of Belarus under the age of 18 with oncological and hematological diseases, primary immunodeficiency disorders and to adults under 30 with some malignant neoplasms.

Written by: belta.by